NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright following positive METIS data
Tweet Send to a Friend
(Updated - March 27, 2024 11:47 AM EDT)
H.C. Wainwright analyst Emily Bodnar raised the price target on NovoCure ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Emily Bodnar raised the price target on NovoCure ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
